Publication May 14, 2019 Update on C-Reactive Protein and Fecal Calprotectin: Are They Accurate Measures of Disease Activity in Crohn’s Disease? Brian Feagan, Christopher Ma, Vipul Jairath Read Now
Publication May 14, 2019 Systematic Review With Meta-Analysis: Efficacy and Safety of Oral Janus Kinase Inhibitors for Inflammatory Bowel Disease Brian Feagan, Christopher Ma, Niels Vande Casteele, Vipul Jairath Read Now
Publication May 14, 2019 IL12/23 or Selective IL23 Inhibition for the Management of Moderate-To-Severe Crohn’s Disease? Brian Feagan, Christopher Ma, Vipul Jairath Read Now
Publication May 14, 2019 Identifying Outcomes in Clinical Trials of Fistulizing Crohn’s Disease for the Development of a Core Outcome Set Brian Feagan, Christopher Ma, Vipul Jairath Read Now
Publication May 14, 2019 Evaluation of Optimal Biopsy Location for Assessment of Histological Activity, Transcriptomic and Immunohistochemical Analyses in Patients With Active Crohn’s Disease Brian Feagan, Geert D’Haens, Guangyong Zou, Niels Vande Casteele, Vipul Jairath Read Now
Publication May 14, 2019 Definitions of Response and Remission for the Robarts Histopathology Index Brian Feagan, Geert D’Haens, Niels Vande Casteele, Vipul Jairath Read Now
